Bone Mineral Density, Plasma Estradiol, and C-Reactive Protein levels in young Oral Contraceptives users vs. Non-users

被引：0
|
作者：
Tsang, Michelle [1 ]
Giltvedt, Kristine [1 ]
Laughlin, Jenna [1 ]
Kern, Mark [1 ]
Hooshmand, Shirin [1 ]
机构：
[1] San Diego State Univ, San Diego, CA 92182 USA
来源：
JOURNAL OF BONE AND MINERAL RESEARCH | 2022年 / 37卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
789
引用
收藏
页码：330 / 331
页数：2
相关论文
共 50 条
  • [21] SERUM LEVELS OF C-TELOPEPTIDES OF TYPE I COLLAGEN, C-REACTIVE PROTEIN AND BONE MINERAL DENSITY IN PATIENTS WITH PSORIATIC ARTHRITIS
    Samakhavets, V.
    Rudenka, E.
    OSTEOPOROSIS INTERNATIONAL, 2015, 26 : S454 - S455
  • [22] Relationship of C-reactive protein and bone mineral density in community-dwelling elderly females
    Ganesan, K
    Teklehaimanot, S
    Tran, TH
    Asuncion, M
    Norris, K
    JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION, 2005, 97 (03) : 329 - 333
  • [23] Increase in C-reactive protein plasma levels during diabetes in infants and young adults
    Coulon, J
    Willems, D
    Dorcby, H
    PRESSE MEDICALE, 2005, 34 (02): : 89 - 93
  • [24] Association between bone mineral density and C-reactive protein in a large population-based sample
    de Pablo, Paola
    Cooper, Mark S.
    Buckley, Christopher D.
    ARTHRITIS AND RHEUMATISM, 2012, 64 (08): : 2624 - 2631
  • [25] Effects of third-generation oral contraceptives on high-sensitivity C-reactive protein and homocysteine in young women
    Cauci, Sabina
    Di Santolo, Manuela
    Culhane, Jennifer F.
    Stel, Giuliana
    Gonano, Tabio
    Guaschino, Secondo
    OBSTETRICS AND GYNECOLOGY, 2008, 111 (04): : 857 - 864
  • [26] Dominant vs. non-dominant hip comparison in bone mineral density in young sporting athletes
    van Santen, James A.
    Pereira, Claudio
    Sanchez-Santos, Maria T.
    Cooper, Cyrus
    Arden, Nigel K.
    ARCHIVES OF OSTEOPOROSIS, 2019, 14 (01)
  • [27] Dominant vs. non-dominant hip comparison in bone mineral density in young sporting athletes
    James A. van Santen
    Claudio Pereira
    Maria T. Sanchez-Santos
    Cyrus Cooper
    Nigel K. Arden
    Archives of Osteoporosis, 2019, 14
  • [28] Differential effects of oral vs. transdermal estrogen replacement therapy on C-reactive protein in postmenopausal women
    Vongpatanasin, W
    Wang, ZY
    Arbique, DA
    Mehrad, B
    Jialal, I
    CIRCULATION, 2002, 106 (19) : 186 - 186
  • [29] High C-reactive protein levels are associated with oral hormonal menopausal therapy but not with intrauterine levonorgestrel and transdermal estradiol
    Blumenfeld, Z.
    Boulman, N.
    Leiba, R.
    Siegler, E.
    Shachar, S.
    Linn, R.
    Levy, Y.
    SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 2007, 67 (03): : 257 - 263
  • [30] Changes in C-reactive protein plasma levels during low-density lipoprotein apheresis
    Kojima, S
    Shida, M
    Yokoyama, H
    THERAPEUTIC APHERESIS AND DIALYSIS, 2003, 7 (04) : 431 - 434
12345